News from the healthcare data industry
Gary Shorter, head of AI and data science at healthcare data goliath IQVIA, is not in a rush as he incorporates machine learning into the company’s suite of services. But he acknowledges that he’s onto something. “Some people think, ‘Oh, you’ve got the golden egg,’” he said in an interview…
Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, granting an accelerated clearance to a Novartis therapy that’s already in use for advanced breast cancer. The FDA’s clearance of the drug, called alpelisib, is based…
April 05, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today that it secured $150 million in Series D financing. SoftBank Vision Fund 2 led the round and was joined by funds and accounts managed by BlackRock and Memorial Hermann Health System, along…
New research published in The BMJ indicates the introduction of low dose CT (LDCT) screening in 2013 coincided with improved survival and a shift toward diagnoses of stage I non–small cell lung cancer (NSCLC). However, data also showed disparities in stage diagnoses persist between patient populations and increased efforts to improve access…
Cytel has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development. Dr Kim brings more than 21 years of interdisciplinary experience in medicine and drug development across a range of therapeutic modalities,…
Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These Patients from French Guiana and Qatar were Few and Mild TORRANCE, Calif., April 7, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
The UK’s Association of the British Pharmaceutical Industry (ABPI) has recently concluded a consultation on its new draft industry governance principles aimed at guiding the pharmaceutical industry when analysing and using health data. Recognising the ‘enormous potential’ in unlocking data, which is routinely collected and stored by the NHS, ‘on everything from…
The Madrid-based company plans to enter the drugs research space while also consolidating its footprint in America and Western Europe Megha Paul 05 April 2022 Real World Data, or the routinely stored data in hospitals, has become extremely valuable to improve clinical trials. AI and big data algorithms are increasingly…
New studies demonstrate the ability of Foundation Medicine’s portfolio of tests to improve treatment options for patients, and reinforce the company’s role as an essential partner to researchers April 05, 2022 07:05 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that the company and its collaborators will…
BOSTON, April 5, 2022 /PRNewswire/ — Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), and AstraZeneca have published results from their ZEPHYR 1 study, the first real-world study documenting the clinical utility and economic benefits of benralizumab, a biologic therapy for patients suffering from eosinophilic asthma. While…